Literature DB >> 8665470

beta-Lactamases in laboratory and clinical resistance.

D M Livermore1.   

Abstract

beta-Lactamases are the commonest single cause of bacterial resistance to beta-lactam antibiotics. Numerous chromosomal and plasmid-mediated types are known and may be classified by their sequences or phenotypic properties. The ability of a beta-lactamase to cause resistance varies with its activity, quantity, and cellular location and, for gram-negative organisms, the permeability of the producer strain. beta-Lactamases sometimes cause obvious resistance to substrate drugs in routine tests; often, however, these enzymes reduce susceptibility without causing resistance at current, pharmacologically chosen breakpoints. This review considers the ability of the prevalent beta-lactamases to cause resistance to widely used beta-lactams, whether resistance is accurately reflected in routine tests, and the extent to which the antibiogram for an organism can be used to predict the type of beta-lactamase that it produces.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8665470      PMCID: PMC172876          DOI: 10.1128/CMR.8.4.557

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  249 in total

1.  beta-Lactamase substrate profiles of coagulase-negative skin staphylococci from orthopaedic inpatients and staff members.

Authors:  M Thore
Journal:  J Hosp Infect       Date:  1992-11       Impact factor: 3.926

2.  Behaviour of TEM-1 beta-lactamase as a resistance mechanism to ampicillin, mezlocillin and azlocillin in Escherichia coli.

Authors:  D M Livermore; F Moosdeen; M A Lindridge; P Kho; J D Williams
Journal:  J Antimicrob Chemother       Date:  1986-02       Impact factor: 5.790

3.  The production and molecular properties of the zinc beta-lactamase of Pseudomonas maltophilia IID 1275.

Authors:  R Bicknell; E L Emanuel; J Gagnon; S G Waley
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

4.  Evolution of plasmid-coded resistance to broad-spectrum cephalosporins.

Authors:  C Kliebe; B A Nies; J F Meyer; R M Tolxdorff-Neutzling; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

5.  The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins.

Authors:  L K McDougal; C Thornsberry
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

6.  Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.

Authors:  A L Barry; P C Fuchs; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

7.  Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.

Authors:  N A Curtis; R L Eisenstadt; C Rudd; A J White
Journal:  J Antimicrob Chemother       Date:  1986-01       Impact factor: 5.790

8.  Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study.

Authors:  G V Doern; J H Jorgensen; C Thornsberry; D A Preston
Journal:  Diagn Microbiol Infect Dis       Date:  1986-02       Impact factor: 2.803

9.  Cefoxitin sensitivity as a marker for inducible beta-lactamases.

Authors:  V A Moritz; P B Carson
Journal:  J Med Microbiol       Date:  1986-05       Impact factor: 2.472

10.  beta-Lactamases and beta-lactam resistance in Escherichia coli.

Authors:  G A Jacoby; L Sutton
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

View more
  419 in total

1.  Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.

Authors:  A Tsakris; S Pournaras; N Woodford; M F Palepou; G S Babini; J Douboyas; D M Livermore
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

2.  Ability of the VITEK 2 advanced expert system To identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  C C Sanders; M Peyret; E S Moland; C Shubert; K S Thomson; J M Boeufgras; W E Sanders
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Contributions of the AmpC beta-lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to beta-lactams.

Authors:  A Mazzariol; G Cornaglia; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

4.  The Legionella (Fluoribacter) gormanii metallo-beta-lactamase: a new member of the highly divergent lineage of molecular-subclass B3 beta-lactamases.

Authors:  L Boschi; P S Mercuri; M L Riccio; G Amicosante; M Galleni; J M Frère; G M Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

5.  ampR gene mutations that greatly increase class C beta-lactamase activity in Enterobacter cloacae.

Authors:  A Kuga; R Okamoto; M Inoue
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

6.  The Red Menace: Emerging Issues in Antimicrobial Resistance in Gram-Negative Bacilli.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

7.  Are SHV beta-lactamases universal in Klebsiella pneumoniae?

Authors:  G S Babini; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

8.  Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-beta-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae.

Authors:  J J Yan; W C Ko; J J Wu
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

9.  Diversity of SHV and TEM beta-lactamases in Klebsiella pneumoniae: gene evolution in Northern Taiwan and two novel beta-lactamases, SHV-25 and SHV-26.

Authors:  F Y Chang; L K Siu; C P Fung; M H Huang; M Ho
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

Review 10.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.